Depression - Dementia and Depression - Cost-Effectiveness of Mirtazapine and Sertraline

被引：0
|
作者：
Lichert, Frank
机构：
来源：
GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT | 2013年 / 18卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：203 / 203
页数：1
相关论文
共 50 条
  • [1] The cost-effectiveness of sertraline in the treatment of depression
    Olvey, Eleanor L.
    Skrepnek, Grant H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (14) : 2497 - 2508
  • [2] Dementia and Depression - Kosteneffektivitaet of Mirtazapine and Sertraline
    Lichert, Frank
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2013, 81 (08) : 419 - 419
  • [3] Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial
    Romeo, Renee
    Knapp, Martin
    Hellier, Jennifer
    Dewey, Michael
    Ballard, Clive
    Baldwin, Robert
    Bentham, Peter
    Burns, Alistair
    Fox, Chris
    Holmes, Clive
    Katona, Cornelius
    Lawton, Claire
    Lindesay, James
    Livingston, Gill
    McCrae, Niall
    Moniz-Cook, Esme
    Murray, Joanna
    Nurock, Shirley
    O'Brien, John
    Poppe, Michaela
    Thomas, Alan
    Walwyn, Rebecca
    Wilson, Kenneth
    Banerjee, Sube
    BRITISH JOURNAL OF PSYCHIATRY, 2013, 202 (02) : 121 - 128
  • [4] Sertraline and mirtazapine do not reduce severity of depression in people with dementia
    Barkin, Robert L.
    EVIDENCE-BASED MENTAL HEALTH, 2012, 15 (01) : 17 - 17
  • [5] Cost-effectiveness of mirtazapine relative to fluoxetine in the treatment of moderate and severe depression in France
    Brown, MCJ
    van Loon, JMT
    Guest, JF
    EUROPEAN JOURNAL OF PSYCHIATRY, 2000, 14 (01): : 15 - 25
  • [6] The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care
    Romeo, R
    Patel, A
    Knapp, M
    Thomas, C
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (03) : 125 - 134
  • [7] Cost-effectiveness of mirtazapine compared to fluoxetine in the treatment of moderate and severe depression in Hungary
    Van Loon, J
    Horvath, LZ
    Faludi, G
    VALUE IN HEALTH, 2002, 5 (06) : 517 - 517
  • [8] Cost-effectiveness of mirtazapine relative to amitriptyline in the treatment of moderate and severe depression in France
    Brown, MCJ
    van Loon, JMT
    Guest, JF
    EUROPEAN JOURNAL OF PSYCHIATRY, 1999, 13 (04): : 197 - 208
  • [9] Study of the use of antidepressants for depression in dementia: the HTA-SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine
    Banerjee, S.
    Hellier, J.
    Romeo, R.
    Dewey, M.
    Knapp, M.
    Ballard, C.
    Baldwin, R.
    Bentham, P.
    Fox, C.
    Holmes, C.
    Katona, C.
    Lawton, C.
    Lindesay, J.
    Livingston, G.
    McCrae, N.
    Moniz-Cook, E.
    Murray, J.
    Nurock, S.
    Orrell, M.
    O'Brien, J.
    Poppe, M.
    Thomas, A.
    Walwyn, R.
    Wilson, K.
    Burns, A.
    HEALTH TECHNOLOGY ASSESSMENT, 2013, 17 (07) : 1 - +
  • [10] Cost-effectiveness of mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in Austria
    Brown, MCJ
    Nimmerrichter, AA
    Guest, JF
    EUROPEAN PSYCHIATRY, 1999, 14 (04) : 230 - 244
12345